Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C5H11NO2 |
Molecular Weight | 117.1463 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC[C@H](N)C(O)=O
InChI
InChIKey=SNDPXSYFESPGGJ-BYPYZUCNSA-N
InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1
Molecular Formula | C5H11NO2 |
Molecular Weight | 117.1463 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1914279 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21955456 |
46.0 mM [Ki] |
PubMed
Title | Date | PubMed |
---|---|---|
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity. | 2001 Feb 1 |
|
Human ornithine transcarbamylase: crystallographic insights into substrate recognition and conformational changes. | 2001 Mar 15 |
|
Conversion of a glutamate dehydrogenase into methionine/norleucine dehydrogenase by site-directed mutagenesis. | 2001 Nov |
|
Sulfamide antifolates inhibiting thymidylate synthase: synthesis, enzyme inhibition and cytotoxicity. | 2002 |
|
Resistance and susceptibility to Marek's disease: nitric oxide synthase/arginase activity balance. | 2002 May 1 |
|
Kinetic analysis of phenylalanine dehydrogenase mutants designed for aliphatic amino acid dehydrogenase activity with guidance from homology-based modelling. | 2003 Dec |
|
Arginine deprivation and tumour cell death: arginase and its inhibition. | 2003 Feb |
|
Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cells. | 2003 Feb 10 |
|
Two new cyclosporin folds observed in the structures of the immunosuppressant cyclosporin G and the formyl peptide receptor antagonist cyclosporin H at ultra-high resolution. | 2003 May 7 |
|
Consumption of L-arginine mediated by Entamoeba histolytica L-arginase (EhArg) inhibits amoebicidal activity and nitric oxide production by activated macrophages. | 2003 Nov-Dec |
|
Arginase pathway in human endothelial cells in pathophysiological conditions. | 2004 Aug |
|
Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction. | 2004 Dec 14 |
|
High glucose augments arginase activity and nitric oxide production in the renal cortex. | 2004 Jul |
|
Arginase activity in a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. | 2006 Jun |
|
Intricate knots in proteins: Function and evolution. | 2006 Sep 15 |
|
Enzymatic evidence for the key role of arginine in nitrogen translocation by arbuscular mycorrhizal fungi. | 2007 Jun |
|
Structural and evolutionary bioinformatics of the SPOUT superfamily of methyltransferases. | 2007 Mar 5 |
|
The crystal structures of ornithine carbamoyltransferase from Mycobacterium tuberculosis and its ternary complex with carbamoyl phosphate and L-norvaline reveal the enzyme's catalytic mechanism. | 2008 Jan 25 |
|
Molecular evolution of B6 enzymes: binding of pyridoxal-5'-phosphate and Lys41Arg substitution turn ribonuclease A into a model B6 protoenzyme. | 2008 Jun 19 |
|
A 3(10)-helical pentapeptide in water: interplay of alpha,alpha-disubstituted amino acids and the central residue on structure formation. | 2009 |
|
Kinetic and thermodynamic control in the stereoselective formation of trans- and cis-2-ferrocenyl-3-pivaloyl-4-alkyl-1,3-oxazolidin-5-ones. | 2009 Feb 7 |
|
Inhibition of S6K1 accounts partially for the anti-inflammatory effects of the arginase inhibitor L-norvaline. | 2009 Mar 13 |
|
Glutathione-supported arsenate reduction coupled to arsenolysis catalyzed by ornithine carbamoyl transferase. | 2009 Sep 1 |
|
Specificities of olfactory receptor neuron responses to amino acids in the black bullhead catfish (Ameiurus melas). | 2010 Feb |
|
Caloric restriction reverses high-fat diet-induced endothelial dysfunction and vascular superoxide production in C57Bl/6 mice. | 2010 May |
|
RNAi-mediated suppression of isoprene emission in poplar transiently impacts phenolic metabolism under high temperature and high light intensities: a transcriptomic and metabolomic analysis. | 2010 Sep |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:31:25 GMT 2023
by
admin
on
Fri Dec 15 16:31:25 GMT 2023
|
Record UNII |
A70UKS48FE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
1076 (Number of products:82)
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
||
|
DSLD |
3256 (Number of products:105)
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
19475
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
229-543-3
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
SUB34283
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
C005313
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
NORVALINE
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
203786
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
6600-40-4
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
DTXSID701018015
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
18314
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
m8075
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | Merck Index | ||
|
65098
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
DB04185
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
100000127966
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY | |||
|
A70UKS48FE
Created by
admin on Fri Dec 15 16:31:25 GMT 2023 , Edited by admin on Fri Dec 15 16:31:25 GMT 2023
|
PRIMARY |